Clinical Trials Directory

Trials / Completed

CompletedNCT01877564

A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic Women

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of Arkansas · Academic / Other
Sex
Female
Age
45 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to determine the effects of Metformin, a well tolerated drug widely prescribed for treatment of Type 2 Diabetes Mellitus, on endometrium cancer patients.

Conditions

Interventions

TypeNameDescription
DRUGMetformin

Timeline

Start date
2013-08-29
Primary completion
2016-08-10
Completion
2017-07-10
First posted
2013-06-13
Last updated
2017-10-25
Results posted
2017-10-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01877564. Inclusion in this directory is not an endorsement.